Other authors consider the utility of the uNGAL/creatinine ratio superior to uNGAL alone in progression monitoring, as it improves the prediction of the progression of kidney disease [18,50] in these patients, and NGAL plasma levels also predict the progression of chronic kidney disease at later stages (3 and 4). The gene discussed is LCN2; the disease is chronic kidney disease.